Neuroendocrine tumor and carcinoma of lung

C3_LUNG_NEUROENDO

No definition available.

Endpoint definition

FinnGen phenotype data

356077 individuals

diagram downward connector

Apply sex-specific rule None

356077

diagram downward connector

Check conditions None

356077

diagram downward connector
diagram bullet

Filter registries

Cancer registry: Topography ICD-O-3 C34
Cancer registry: Morphology ICD-O-3 8240|8246|8249

5083

diagram downward connector

Check pre-conditions, main-only, mode, ICD version None

148

diagram downward connector

Check minimum number of events None

148

diagram downward connector

Include endpoints None

148

diagram downward connector
C3_LUNG_NEUROENDO

Extra metadata

Level in the ICD hierarchy C
First used in FinnGen datafreeze DF8

Summary Statistics

Key figures

All Female Male
Number of individuals 148 88 60
Unadjusted prevalence (%) 0.04 0.04 0.04
Mean age at first event (years) 60.86 59.32 63.10

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 - - - -
15 years - - - -
5 years - - - -
1 year - - - -

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

Index endpoint: C3_LUNG_NEUROENDO – Neuroendocrine tumor and carcinoma of lung
GWS hits:

Survival analyses between endpoints

Plot

before Neuroendocrine tumor and carcinoma of lung
after Neuroendocrine tumor and carcinoma of lung

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Neuroendocrine tumor and carcinoma of lung